Original document(33 pages)  中文版
    The invention provides a traditional Chinese medicinal composition for treating damp-heat rheumatism, which is prepared from twelve kinds of Chinese herbs including atractylodes rhizome, corktree bark, honey-suckle stem and tetrandra root, the dosage types include any pharmacologically acceptable oral medications. The invention also provides the process for preparing the Chinese medicament, especially the process for preparing dispersible tablet, micro balloons and capsules, as well as the preparing process.
Application Number
申请号
200510114423 Application Date
申请日
2005.10.25
Title 名称 Chinese medicine for treating damp heat arthralgia and its preparation method
Publication Number
公开号
1799613 Publication Date
公开日
2006.07.12
Approval Pub. Date Granted Pub. Date
International Classification 分类号 A61K36/8994,A61P29/00
Applicant(s) Name
申请人
Liaoning Huayuan Benxi Third Pharmaceutical Limited Company
Address 地址 117004
Inventor(s) Name 发明人 Wang Yongyan, Jiang Yunxian, Ji Dongchang
Attorney & Agent 代理人

  
Secondary Chinese patent medicine recipe developing, optimizing and screening method
Oral preparation for cerebral embolism and its preparing method
Chinese traditional medicine or natural medicine compound activity assessment method and purpose thereof
Method and use for Chinese medicine and natural medicine compound active screening
Compound Chinese medicinal extract mixture and its prepration method
Combination of Chinese traditional medicine for curing vascular dementia and preparation method
Flavonoid extract product containing pedaliin and application
Pharmaceutical composition for treating cerebral apoplexy and its preparation method
Chinese medicines for stomach pain due to Qi stagnation and its preparing method
Medicine for treating parkinson's disease and Parkinson's syndrome and its prepn
Google
Note:All patent data come from State Intellectual Property Office of the People's Republic of China. If there were discrepancies between here and the State Intellectual Property office, the later is more accurate. The patent data is only for public exchange and learning purposes. We are not responsible for the adverse consequences with unverified use of the data.